AVT (Shanghai) Pharmaceutical Tech Co., Ltd.

[About Us] Founded in 2007, AVT (Shanghai) Pharmaceutical Tech Co., Ltd. (hereinafter referred to as AVT) specializes in providing high quality excipients and services for advanced injections. The company’s products range from high quality traditional injection grade phospholipid excipients applied for liposomes and fat emulsions, such as natural phospholipids, HSPC, DSPE-PEG2000, CHO, etc.; as well as protective agents and buffers salts used in vaccines, antibody proteins, antibody-conjugated drugs and other biological formulations, such as trehalose, sucrose, sucrose potassium octasulfate, etc. AVT has always pursued to develop high purity, low endotoxin excipients aimed for injections. Our products are manufactured in accordance with GMP guidelines and under strict in-house quality control standards, these products can meet requirements of mainstream pharmacopoeias including ChP, NF, EP, and JP. We have established steady cooperation with domestic mainstream pharmaceutical companies and emerging biological companies. [Product Technology Highlights] High purity, low endotoxin, injectable grade carbohydrate protective agent and buffer salt; High purity, low endotoxin, injection grade phospholipid applied for fat emulsion and liposomes; Commercial-scale production in accordance with GMP guidelines; Meet the requirements of mainstream pharmacopoeia and able to assist in drug registration; Sufficient production capacity and stable supply chain.